No Data
No Data
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
P3 Health Partners Analyst Ratings
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Maintains Target Price $0.25
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Cuts Target Price to $0.25
P3 Health Partners Faces Increased Operating Losses and Capital Raise Needs Amid Negative EBITDA Adjustments
Analysts Have Lowered Expectations For P3 Health Partners Inc. (NASDAQ:PIII) After Its Latest Results
No Data